Page last updated: 2024-09-03

2-pyrrolino-dox and Body Weight

2-pyrrolino-dox has been researched along with Body Weight in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Engel, JB; Halmos, G; Hammann, B; Keller, G; Nagy, A; Schally, AV	1
Groot, K; Koppan, M; Kovacs, M; Nagy, A; Schally, AV	1

Other Studies

2 other study(ies) available for 2-pyrrolino-dox and Body Weight

Article	Year
Growth inhibition of experimental non-Hodgkin's lymphomas with the targeted cytotoxic somatostatin analogue AN-238. International journal of cancer, 2005, May-01, Volume: 114, Issue:5 Topics: Animals; Antineoplastic Agents; Body Weight; Doxorubicin; Humans; Kinetics; Leukocytes; Lymphoma, Non-Hodgkin; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Peptides; Pyrroles; Receptors, Somatostatin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Somatostatin; Time Factors	2005
Recovery of pituitary function after treatment with a targeted cytotoxic analog of luteinizing hormone-releasing hormone. Proceedings of the National Academy of Sciences of the United States of America, 1997, Feb-18, Volume: 94, Issue:4 Topics: Animals; Antineoplastic Agents; Body Weight; Cytotoxins; Doxorubicin; Female; Gonadotropin-Releasing Hormone; Growth Hormone; Luteinizing Hormone; Menstrual Cycle; Pituitary Function Tests; Pituitary Gland, Anterior; Pyrroles; Rats; Rats, Sprague-Dawley; Thyrotropin	1997

Article

Year

Growth inhibition of experimental non-Hodgkin's lymphomas with the targeted cytotoxic somatostatin analogue AN-238.

International journal of cancer, 2005, May-01, Volume: 114, Issue:5

Topics: Animals; Antineoplastic Agents; Body Weight; Doxorubicin; Humans; Kinetics; Leukocytes; Lymphoma, Non-Hodgkin; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Peptides; Pyrroles; Receptors, Somatostatin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Somatostatin; Time Factors

2005

Recovery of pituitary function after treatment with a targeted cytotoxic analog of luteinizing hormone-releasing hormone.

Proceedings of the National Academy of Sciences of the United States of America, 1997, Feb-18, Volume: 94, Issue:4

Topics: Animals; Antineoplastic Agents; Body Weight; Cytotoxins; Doxorubicin; Female; Gonadotropin-Releasing Hormone; Growth Hormone; Luteinizing Hormone; Menstrual Cycle; Pituitary Function Tests; Pituitary Gland, Anterior; Pyrroles; Rats; Rats, Sprague-Dawley; Thyrotropin

1997